bioscience ltd.
bioscience ltd. Company Information
Company Number
06454077
Next Accounts
Sep 2025
Shareholders
gather steam inc.
Group Structure
View All
Industry
Other personal service activities n.e.c.
Registered Address
175 darkes lane, brosnan house, suite 2b, potters bar, england, EN6 1BW
Website
www.ebioscience.combioscience ltd. Estimated Valuation
Pomanda estimates the enterprise value of BIOSCIENCE LTD. at £99.1k based on a Turnover of £144.5k and 0.69x industry multiple (adjusted for size and gross margin).
bioscience ltd. Estimated Valuation
Pomanda estimates the enterprise value of BIOSCIENCE LTD. at £37.3k based on an EBITDA of £8.3k and a 4.51x industry multiple (adjusted for size and gross margin).
bioscience ltd. Estimated Valuation
Pomanda estimates the enterprise value of BIOSCIENCE LTD. at £374.8k based on Net Assets of £191.1k and 1.96x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Bioscience Ltd. Overview
Bioscience Ltd. is a live company located in potters bar, EN6 1BW with a Companies House number of 06454077. It operates in the other service activities n.e.c. sector, SIC Code 96090. Founded in December 2007, it's largest shareholder is gather steam inc. with a 100% stake. Bioscience Ltd. is a established, micro sized company, Pomanda has estimated its turnover at £144.5k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Bioscience Ltd. Health Check
Pomanda's financial health check has awarded Bioscience Ltd. a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
4 Regular
4 Weak
Size
annual sales of £144.5k, make it smaller than the average company (£1.2m)
- Bioscience Ltd.
£1.2m - Industry AVG
Growth
3 year (CAGR) sales growth of -33%, show it is growing at a slower rate (7.9%)
- Bioscience Ltd.
7.9% - Industry AVG
Production
with a gross margin of 42%, this company has a comparable cost of product (42%)
- Bioscience Ltd.
42% - Industry AVG
Profitability
an operating margin of 5.7% make it as profitable than the average company (6.4%)
- Bioscience Ltd.
6.4% - Industry AVG
Employees
with 1 employees, this is below the industry average (15)
1 - Bioscience Ltd.
15 - Industry AVG
Pay Structure
on an average salary of £34.5k, the company has an equivalent pay structure (£34.5k)
- Bioscience Ltd.
£34.5k - Industry AVG
Efficiency
resulting in sales per employee of £144.5k, this is more efficient (£104.2k)
- Bioscience Ltd.
£104.2k - Industry AVG
Debtor Days
it gets paid by customers after 31 days, this is near the average (31 days)
- Bioscience Ltd.
31 days - Industry AVG
Creditor Days
its suppliers are paid after 210 days, this is slower than average (40 days)
- Bioscience Ltd.
40 days - Industry AVG
Stock Days
it holds stock equivalent to 14 days, this is less than average (40 days)
- Bioscience Ltd.
40 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 47 weeks, this is more cash available to meet short term requirements (38 weeks)
47 weeks - Bioscience Ltd.
38 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 55.4%, this is a higher level of debt than the average (48%)
55.4% - Bioscience Ltd.
48% - Industry AVG
BIOSCIENCE LTD. financials
Bioscience Ltd.'s latest turnover from December 2023 is estimated at £144.5 thousand and the company has net assets of £191.1 thousand. According to their latest financial statements, Bioscience Ltd. has 1 employee and maintains cash reserves of £53.7 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 16,200 | 14,050 | 12,350 | ||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | 1 | 1 | 1 | 2 | |||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | 348,879 | 83,385 | 83,385 | 83,385 | 83,385 | 83,385 | 83,385 | 61,735 | 61,735 | 61,735 | |||||
| Debtors (Due After 1 year) | 4,487 | 267,271 | |||||||||||||
| Total Fixed Assets | 353,366 | 350,656 | 83,385 | 83,385 | 83,385 | 83,385 | 83,385 | 61,735 | 61,735 | 61,735 | |||||
| Stock & work in progress | 3,341 | 3,341 | 3,341 | 3,341 | 38,693 | ||||||||||
| Trade Debtors | 12,491 | 7,304 | 1,921 | 150 | 100 | 50 | 300 | ||||||||
| Group Debtors | |||||||||||||||
| Misc Debtors | 39,754 | 279,385 | 224,849 | 130,350 | 54,220 | 10,193 | 17,022 | 1,771 | |||||||
| Cash | 53,671 | 42,479 | 5,201 | 16,216 | 41,304 | 20,150 | 27,045 | 2,998 | 862 | 1,711 | 1,450 | 16,237 | 1,300 | 1,400 | 1,000 |
| misc current assets | 5,039 | 3,110 | 1,350 | ||||||||||||
| total current assets | 74,542 | 88,684 | 289,277 | 244,406 | 210,347 | 74,370 | 37,238 | 27,324 | 2,633 | 3,632 | 1,600 | 16,237 | 1,400 | 1,450 | 1,300 |
| total assets | 427,908 | 439,340 | 372,662 | 327,791 | 293,732 | 157,755 | 120,623 | 89,059 | 64,368 | 65,367 | 1,600 | 16,237 | 1,400 | 1,450 | 1,300 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 48,330 | 243,092 | 206,597 | 205,051 | 203,977 | 107,713 | 78,572 | 52,108 | 44,947 | 38,795 | 180 | 230 | 250 | 50 | |
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 10,133 | 13,163 | 11,309 | 15,953 | 8,288 | 3,907 | 3,336 | 1,650 | 2,865 | ||||||
| total current liabilities | 58,463 | 256,255 | 217,906 | 221,004 | 212,265 | 111,620 | 81,908 | 53,758 | 47,812 | 38,795 | 180 | 230 | 250 | 50 | |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | 178,394 | 133 | 133 | 375 | 375 | 375 | 2,241 | 6,655 | 3,402 | 23,044 | 375 | 44,167 | 120 | 170 | 200 |
| provisions | |||||||||||||||
| total long term liabilities | 178,394 | 133 | 133 | 375 | 375 | 375 | 2,241 | 6,655 | 3,402 | 23,044 | 375 | 44,167 | 120 | 170 | 200 |
| total liabilities | 236,857 | 256,388 | 218,039 | 221,379 | 212,640 | 111,995 | 84,149 | 60,413 | 51,214 | 61,839 | 555 | 44,167 | 350 | 420 | 250 |
| net assets | 191,051 | 182,952 | 154,623 | 106,412 | 81,092 | 45,760 | 36,474 | 28,646 | 13,154 | 3,528 | 1,045 | -27,930 | 1,050 | 1,030 | 1,050 |
| total shareholders funds | 191,051 | 182,952 | 154,623 | 106,412 | 81,092 | 45,760 | 36,474 | 28,646 | 13,154 | 3,528 | 1,045 | -27,930 | 1,050 | 1,030 | 1,050 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | |||||||||||||||
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | -35,352 | 38,693 | |||||||||||||
| Debtors | -290,047 | 27,640 | 54,536 | 94,499 | 76,130 | 44,027 | -14,133 | 22,555 | -150 | 1,771 | 150 | -100 | 50 | -250 | 300 |
| Creditors | -194,762 | 36,495 | 1,546 | 1,074 | 96,264 | 29,141 | 26,464 | 7,161 | 6,152 | 38,615 | 180 | -230 | -20 | 200 | 50 |
| Accruals and Deferred Income | -3,030 | 1,854 | -4,644 | 7,665 | 4,381 | 571 | 1,686 | -1,215 | 2,865 | ||||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 265,494 | 21,650 | 61,735 | ||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | 178,261 | -242 | -1,866 | -4,414 | 3,253 | -19,642 | 22,669 | -43,792 | 44,047 | -50 | -30 | 200 | |||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | 11,192 | 37,278 | -11,015 | -25,088 | 21,154 | -6,895 | 24,047 | 2,136 | -849 | 261 | -14,787 | 14,937 | -100 | 400 | 1,000 |
| overdraft | |||||||||||||||
| change in cash | 11,192 | 37,278 | -11,015 | -25,088 | 21,154 | -6,895 | 24,047 | 2,136 | -849 | 261 | -14,787 | 14,937 | -100 | 400 | 1,000 |
bioscience ltd. Credit Report and Business Information
Bioscience Ltd. Competitor Analysis
Perform a competitor analysis for bioscience ltd. by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other micro companies, companies in EN6 area or any other competitors across 12 key performance metrics.
bioscience ltd. Ownership
BIOSCIENCE LTD. group structure
Bioscience Ltd. has no subsidiary companies.
Ultimate parent company
BIOSCIENCE LTD.
06454077
bioscience ltd. directors
Bioscience Ltd. currently has 2 directors. The longest serving directors include Mr Keith Ridgway (May 2015) and Ms Viktoriia Bandyk (Sep 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Keith Ridgway | England | 74 years | May 2015 | - | Director |
| Ms Viktoriia Bandyk | United Kingdom | 44 years | Sep 2017 | - | Director |
P&L
December 2023turnover
144.5k
-69%
operating profit
8.3k
0%
gross margin
42%
+0.88%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
191.1k
+0.04%
total assets
427.9k
-0.03%
cash
53.7k
+0.26%
net assets
Total assets minus all liabilities
bioscience ltd. company details
company number
06454077
Type
Private limited with Share Capital
industry
96090 - Other personal service activities n.e.c.
incorporation date
December 2007
age
18
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
-
address
175 darkes lane, brosnan house, suite 2b, potters bar, england, EN6 1BW
Bank
-
Legal Advisor
-
bioscience ltd. Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to bioscience ltd..
bioscience ltd. Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOSCIENCE LTD.. This can take several minutes, an email will notify you when this has completed.
bioscience ltd. Companies House Filings - See Documents
| date | description | view/download |
|---|
